Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4636206
Max Phase: Preclinical
Molecular Formula: C12H16N4S
Molecular Weight: 248.35
Molecule Type: Unknown
Associated Items:
ID: ALA4636206
Max Phase: Preclinical
Molecular Formula: C12H16N4S
Molecular Weight: 248.35
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(CN)Nc1cccc2cc(C(=N)N)sc12
Standard InChI: InChI=1S/C12H16N4S/c1-7(6-13)16-9-4-2-3-8-5-10(12(14)15)17-11(8)9/h2-5,7,16H,6,13H2,1H3,(H3,14,15)
Standard InChI Key: ZAZAVGHCOORPKF-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 248.35 | Molecular Weight (Monoisotopic): 248.1096 | AlogP: 1.94 | #Rotatable Bonds: 4 |
Polar Surface Area: 87.92 | Molecular Species: BASE | HBA: 4 | HBD: 4 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 9.86 | CX LogP: 0.99 | CX LogD: -3.09 |
Aromatic Rings: 2 | Heavy Atoms: 17 | QED Weighted: 0.49 | Np Likeness Score: -0.65 |
1. Guillory X, Wolter M, Leysen S, Neves JF, Kuusk A, Genet S, Somsen B, Morrow JK, Rivers E, van Beek L, Patel J, Goodnow R, Schoenherr H, Fuller N, Cao Q, Doveston RG, Brunsveld L, Arkin MR, Castaldi P, Boyd H, Landrieu I, Chen H, Ottmann C.. (2020) Fragment-based Differential Targeting of PPI Stabilizer Interfaces., 63 (13): [PMID:32501690] [10.1021/acs.jmedchem.9b01942] |
Source(1):